Page 1700 - Hematology_ Basic Principles and Practice ( PDFDrive )

1512.e6 Part VIII Comprehensive Care of Patients with Hematologic Malignancies

213. Strasser SI, Sullivan KM, Myerson D, et al: Cirrhosis of the liver in report From the Late Effects Study Group. J Clin Oncol 21(23):4386–
long-term marrow transplant survivors. Blood 93(10):3259–3266, 4394, 2003.
1999. 238. Bhatia S, Robison LL, Oberlin O, et al: Breast cancer and other
214. McDonald GB: Hepatobiliary complications of hematopoietic cell second neoplasms after childhood Hodgkin’s disease. N Engl J Med
transplantation, 40 years on. Hepatology 51(4):1450–1460, 2010. 334:745–751, 1996.
215. McKay PJ, Murphy JA, Cameron S, et al: Iron overload and liver 239. Metayer C, Lynch CF, Clarke EA, et al: Second cancers among
dysfunction after allogeneic or autologous bone marrow transplanta- long-term survivors of Hodgkin’s disease diagnosed in childhood and
tion. Bone Marrow Transplant 17(1):63–66, 1996. adolescence. J Clin Oncol 18(12):2435–2443, 2000.
216. Sankila R, Pukkala E, Teppo L: Risk of subsequent malignant neoplasms 240. Wolden SL, Lamborn KR, Cleary SF, et al: Second cancers following
among 470,000 cancer patients in Finland, 1953-1991. Int J Cancer pediatric Hodgkin’s disease. J Clin Oncol 16(2):536–544, 1998.
60:464–470, 1995. 241. Sankila R, Garwicz S, Olsen JH, et al: Risk of subsequent malignant
217. Dong C, Hemminki K: Second primary neoplasms in 633,964 cancer neoplasms among 1,641 Hodgkin’s disease patients diagnosed in child-
patients in Sweden, 1958-1996. Int J Cancer 93:155–161, 2001. hood and adolescence: a population-based cohort study in the five
218. Dong C, Hemminki K: Second primary neoplasms among 53 159 hae- Nordic countries. Association of the Nordic Cancer Registries and the
matolymphoproliferative malignancy patients in Sweden, 1958-1996: a Nordic Society of Pediatric Hematology and Oncology. J Clin Oncol
search for common mechanisms. Br J Cancer 85(7):997–1005, 2001. 14(5):1442–1446, 1996.
219. Friedman DL, Whitton J, Leisenring W, et al: Subsequent neoplasms in 242. Castellino SM, Geiger AM, Mertens AC, et al: Morbidity and mortal-
5-year survivors of childhood cancer: the Childhood Cancer Survivor ity in long-term survivors of Hodgkin lymphoma: a report from the
Study. J Natl Cancer Inst 102(14):1083–1095, 2010. Childhood Cancer Survivor Study. Blood 117(6):1806–1816, 2011.
220. Mertens AC, Liu Q, Neglia JP, et al: Cause-specific late mortality 243. Tucker MA, Coleman CN, Cox RS, et al: Risk of second cancers
among 5-year survivors of childhood cancer: the Childhood Cancer after treatment for Hodgkin’s disease. N Engl J Med 318(2):76–81,
Survivor Study. J Natl Cancer Inst 100(19):1368–1379, 2008. 1988.
221. Armstrong GT, Liu W, Leisenring W, et al: Occurrence of multiple 244. Kaldor JM, Day NE, Clarke EA, et al: Leukemia following Hodgkin’s
subsequent neoplasms in long-term survivors of childhood cancer: disease. N Engl J Med 322(1):7–13, 1990.
a report from the childhood cancer survivor study. J Clin Oncol 245. Van Leeuwen FE, Klokman WJ, Stovall M, et al: Roles of radiotherapy
29(22):3056–3064, 2011. and smoking in lung cancer following Hodgkin’s disease. J Natl Cancer
222. Rizzo JD, Curtis RE, Socie G, et al: Solid cancers after allogeneic Inst 87:1530–1537, 1995.
hematopoietic cell transplantation. Blood 113(5):1175–1183, 2009. 246. Deutsch M, Wollman MR, Ramanathan R, et al: Rectal cancer twenty-
223. Bhatia S, Louie AD, Bhatia R, et al: Solid cancers after bone marrow one years after treatment of childhood Hodgkin disease. Med Pediatr
transplantation. J Clin Oncol 19(2):464–471, 2001. Oncol 38(4):280–281, 2002.
224. Bhatia S, Ramsay NK, Steinbuch M, et al: Malignant neoplasms fol- 247. Dores GM, Metayer C, Curtis RE, et al: Second malignant neoplasms
lowing bone marrow transplantation. Blood 87(9):3633–3639, 1996. among long-term survivors of Hodgkin’s disease: a population-based
225. Curtis RE, Rowlings PA, Deeg HJ, et al: Solid cancers after bone evaluation over 25 years. J Clin Oncol 20(16):3484–3494, 2002.
marrow transplantation. N Engl J Med 336(13):897–904, 1997. 248. Kenney LB, Yasui Y, Inskip PD, et al: Breast cancer after childhood
226. Krishnan A, Bhatia S, et al: Predictors of therapy-related leukemia and cancer: a report from the Childhood Cancer Survivor Study. Ann Intern
myelodysplasia following autologous transplantation for lymphoma: an Med 141(8):590–597, 2004.
assessment of risk factors. Blood 95:1588–1593, 2000. 249. Ng AK, Bernardo MV, Weller E, et al: Second malignancy after Hodgkin
227. Bhatia S, Robison LL, Francisco L, et al: Late mortality in survivors of disease treated with radiation therapy with or without chemotherapy:
autologous hematopoietic-cell transplantation: report from the Bone long-term risks and risk factors. Blood 100(6):1989–1996, 2002.
Marrow Transplant Survivor Study. Blood 105(11):4215–4222, 2005. 250. Swerdlow AJ, Barber JA, Hudson GV, et al: Risk of second malignancy
228. Vardiman JW, Thiele J, Arber DA, et al: The 2008 revision of the after Hodgkin’s disease in a collaborative British cohort: the relation to
World Health Organization (WHO) classification of myeloid neo- age at treatment. J Clin Oncol 18(3):498–509, 2000.
plasms and acute leukemia: rationale and important changes. Blood 251. Hodgson DC, Gilbert ES, Dores GM, et al: Long-term solid cancer
114(5):937–951, 2009. risk among 5-year survivors of Hodgkin’s lymphoma. J Clin Oncol
229. Neglia JP, Meadows AT, Robison LL, et al: Second neoplasms after acute 25(12):1489–1497, 2007.
lymphoblastic leukemia in childhood. N Engl J Med 325:1330–1336, 252. Henderson TO, Amsterdam A, Bhatia S, et al: Systematic review:
1991. surveillance for breast cancer in women treated with chest radiation
230. Bhatia S, Sather HN, Pabustan OB, et al: Low incidence of second neo- for childhood, adolescent, or young adult cancer. Ann Intern Med
plasms among children diagnosed with acute lymphoblastic leukemia 152(7):444–455, W144-454, 2010.
after 1983. Blood 99:4257–4264, 2002. 253. Guibout C, Adjadj E, Rubino C, et al: Malignant breast tumors
231. Perkins SM, Dewees T, Shinohara ET, et al: Risk of subsequent after radiotherapy for a first cancer during childhood. J Clin Oncol
malignancies in survivors of childhood leukemia. J Cancer Surviv 23(1):197–204, 2005.
7(4):544–550, 2013. 254. Jenkinson HC, Hawkins MM, Stiller CA, et al: Long-term population-
232. Neglia JP, Friedman DL, Yutaka Y, et al: Second malignant neoplasms based risks of second malignant neoplasms after childhood cancer in
in five-year survivors of childhood cancer: Childhood cancer survivor Britain. Br J Cancer 91(11):1905–1910, 2004.
study. J Natl Cancer Inst 93:618–629, 2001. 255. Inskip PD, Curtis RE: New malignancies following childhood cancer
233. Hijiya N, Hudson MM, Lensing S, et al: Cumulative incidence of in the United States, 1973-2002. Int J Cancer 121(10):2233–2240,
secondary neoplasms as a first event after childhood acute lymphoblastic 2007.
leukemia. JAMA 297(11):1207–1215, 2007. 256. Taylor AJ, Winter DL, Stiller CA, et al: Risk of breast cancer in female
234. Pui CH, Cheng C, Leung W, et al: Extended follow-up of long-term survivors of childhood Hodgkin’s disease in Britain: a population-based
survivors of childhood acute lymphoblastic leukemia. N Engl J Med study. Int J Cancer 120(2):384–391, 2007.
349(7):640–649, 2003. 257. Travis LB, Hill DA, Dores GM, et al: Breast cancer following radio-
235. Pui CH, Ribeiro RC, Hancock ML, et al: Acute myeloid leukemia therapy and chemotherapy among young women with Hodgkin disease.
in children treated with epipodophyllotoxins for acute lymphoblastic JAMA 290(4):465–475, 2003.
leukemia. N Engl J Med 325(24):1682–1687, 1991. 258. Inskip PD, Robison LL, Stovall M, et al: Radiation dose and breast
236. Smith MA, Rubinstein L, Anderson JR, et al: Secondary leukemia or cancer risk in the childhood cancer survivor study. J Clin Oncol
myelodysplastic syndrome after treatment with epipodophyllotoxins. J 27(24):3901–3907, 2009.
Clin Oncol 17:569–577, 1999. 259. Moskowitz CS, Chou JF, Wolden SL, et al: Breast cancer after chest
237. Bhatia S, Yasui Y, Robison LL, et al: High risk of subsequent neoplasms radiation therapy for childhood cancer. J Clin Oncol 32(21):2217–2223,
continues with extended follow-up of childhood Hodgkin’s disease: 2014.